Cancer News and Research

Latest Cancer News and Research

UHCC researchers identify role of RSK2 protein in cancer cell migration

Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.

27 Feb 2013

XBiotech to enter biosimilar business

XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.

26 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Genetic variation in CD33 influences how AML patients' leukemic cell responds to GO

Researchers from the College of Pharmacy and Medical School working within the Masonic Cancer Center, University of Minnesota, have partnered to identify genetic variations that may help signal which acute myeloid leukemia (AML) patients will benefit or not benefit from one of the newest antileukemic agents.

26 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

Women who have had the lymph nodes under their arm surgically removed during breast cancer treatment are warned to avoid certain practices that can cause lymphedema-a condition that causes chronic, painless swelling in the arm.

26 Feb 2013

Conference aims to end tobacco epidemic in developing nations

Imagine, for a moment, that a plague has ravaged the Developed World, but has not yet established its grip on the Developing Nations. If the world's leaders in public health came together for two days at Harvard to map out a campaign to prevent the plague's spread, wouldn't you want to cover that meeting?

26 Feb 2013

Societies advocate some change for colonoscopy patients with Medicare

The federal government has issued an important clarification on preventive screening benefits under the Affordable Care Act. Patients with private insurance will no longer be liable for cost sharing when a pre-cancerous colon polyp is removed during screening colonoscopy.

26 Feb 2013

Loss of Dickopf-1 restores neurogenesis and memory in animal model

Loss of the molecule Dickopf-1 in the hippocampus in older animals increases neurogenesis, research shows.

26 Feb 2013

Ill health more likely to be responsible for retirement in regional areas than in cities

Men and women of working age, living in regional areas are more likely to be fully retired because of ill health than their city counterparts, University of Sydney research shows.

26 Feb 2013

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

Quinten, a strategic and operational consulting company specializing in the evaluation of biomedical data in the pharmaceutical, biotechnology and cosmetic industries, today announces the identification of two discriminating biological marker candidates which are indicative of a favorable response to treatment in women suffering from triple-negative breast cancer (TNBC).

26 Feb 2013

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.

26 Feb 2013

4SC Discovery enters exclusive research and license agreement with LEO Pharma

LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into an exclusive research and license agreement with the German biotech company 4SC Discovery GmbH with the primary aim of jointly researching, developing and commercialising an oral treatment for inflammatory skin diseases such as psoriasis.

26 Feb 2013

Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Researchers at UCLA report that they have refined a method they previously developed for capturing and analyzing cancer cells that break away from patients' tumors and circulate in the blood. With the improvements to their device, which uses a Velcro-like nanoscale technology, they can now detect and isolate single cancer cells from patient blood samples for analysis.

26 Feb 2013

Study finds major risk factor behind increased risk of adverse outcomes in IVF pregnancies

Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).

26 Feb 2013

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of Virology.

26 Feb 2013

Robert Wood Johnson Medical Group physicians appear on the Best Doctors in America List

Eighty-five physicians affiliated with The Robert Wood Johnson Medical Group, the faculty practice of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, appear on the Best Doctors in America List for 2013.

26 Feb 2013

HDAC-mediated mechanisms play critical role in regulating lung repair and regeneration

Lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) are on the rise, according to the American Lung Association and the National Institutes of Health.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Survey finds 65% of Missouri salons would allow pre-teens to use tanning beds

A survey of tanning salon operators in Missouri shows that 65 percent would allow children as young as 10 to 12 years old to use tanning beds. That's despite evidence that any tanning bed use increases the risk of all skin cancers, including melanoma, the deadliest form of skin cancer, later in life.

26 Feb 2013

Cancer News and Research

Latest Cancer News and Research

UHCC researchers identify role of RSK2 protein in cancer cell migration

XBiotech to enter biosimilar business

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Genetic variation in CD33 influences how AML patients' leukemic cell responds to GO

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

Conference aims to end tobacco epidemic in developing nations

Societies advocate some change for colonoscopy patients with Medicare

Loss of Dickopf-1 restores neurogenesis and memory in animal model

Ill health more likely to be responsible for retirement in regional areas than in cities

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

4SC Discovery enters exclusive research and license agreement with LEO Pharma

Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Study finds major risk factor behind increased risk of adverse outcomes in IVF pregnancies

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Robert Wood Johnson Medical Group physicians appear on the Best Doctors in America List

HDAC-mediated mechanisms play critical role in regulating lung repair and regeneration

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

Survey finds 65% of Missouri salons would allow pre-teens to use tanning beds

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in